[Long-term tolerance. Favorable lipid profile--favorable effect on development of lipodystrophy?].
D000328:Adult; D000069446:Atazanavir Sulfate; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015497:HIV-1 / Q000187:drug effects*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood*; D008134:Long-Term Care; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects
D003692:Delayed-Action Preparations; D017320:HIV Protease Inhibitors; D008055:Lipids; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate
Langzeitverträglichkeit. Günstiges Lipidprofil--günstiger Einfluss auf die Entwicklung einer Lipodystrophie?